Article2020

Blood use and transfusion needs at a large health care system in Washington state during the SARS‐CoV ‐2 pandemic

Monica B. Pagano · Guido Cataife · Kleber Yotsumoto Fertrin · Terry Gernsheimer · John Rider Hess · Elizabeth M. Staley +3 more

15 citations0/0 files storedTransfusion

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Blood donation and transfusion practices COVID-19 Clinical Research Studies Blood transfusion and management

Abstract

BACKGROUND: This report evaluates hospital blood use trends during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, and identifies factors associated with the need for transfusion and risk of death in patients with coronavirus 2019 (COVID-19). METHODS: Overall hospital blood use and medical records of adult patients with COVID-19 were extracted for two institutions. Multivariate logistic regression models were conducted to estimate associations between the outcomes transfusion and mortality and patient factors. RESULTS: Daily blood use decreased compared to pre-COVID-19 levels; the effect was more significant for platelets (29% and 34%) compared to red blood cells (25% and 20%) at the two institutions, respectively. Surgical and oncologic services had a decrease in average daily use of platelets of 52% and 30%, and red blood cells of 39% and 25%, respectively. A total of 128 patients with COVID-19 were hospitalized, and 13 (10%) received at least one transfusion due to anemia secondary to chronic illness (n = 7), recent surgery (n = 3), and extracorporeal membrane oxygenation (n = 3). Lower baseline platelet count and admission to the intensive care unit were associated with increased risk of transfusion. The blood group distribution in patients with COVID-19 was 37% group O, 40% group A, 18% group B, and 5% group AB. Non-type O was not associated with increased risk of mortality. CONCLUSION: The response to the SARS-CoV-2 pandemic included changes in routine hospital operations that allowed for the provision of a sufficient level of care for patients with and without COVID-19. Although blood type may play a role in COVID-19 susceptibility, it did not seem to be associated with patient mortality.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 15 citations exist upstream.

References

2020Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus ( COVID ‐19) pandemic affecting Washington State 2007Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States

Cited by

2021Hospital transfusion service operations during the SARS‐CoV ‐2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak 2022Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID ‐19 pandemic: The BEST collaborative study 2021Blood usage at a large academic center in Maryland in relation to the COVID ‐19 pandemic in 2020 2021Impacts of COVID ‐19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia 2021National level adjustments to the challenges of the SARS‐CoV2 pandemic on blood banking operations

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.